US 8309580
Heterocyclic compound
granted A61PA61P3/10
Quick answer
US patent 8309580 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P3/10